<?xml version="1.0" encoding="UTF-8"?>
<p id="Par69">Taking the aforementioned into account, the design of new antiviral MSNs can be an effective approach to control viral infections inhibiting virus mechanism action by interaction with virus, targeted drug delivery, interaction with host cells receptors inducing cellular immune response (
 <xref ref-type="bibr" rid="CR6">6</xref>,
 <xref ref-type="bibr" rid="CR146">146</xref>,
 <xref ref-type="bibr" rid="CR147">147</xref>,
 <xref ref-type="bibr" rid="CR158">158</xref>,
 <xref ref-type="bibr" rid="CR159">159</xref>).
</p>
